Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanner, C. M.
Right arrow Articles by Klawans, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanner, C. M.
Right arrow Articles by Klawans, H. L.
NEUROLOGY 1982;32:1315
© 1982 American Academy of Neurology

Cholinergic mechanisms in Tourette syndrome

Caroline M. Tanner, M.D., Christopher G. Goetz, M.D. and Harold L. Klawans, M.D.

Department of Neurological Sciences, Rush-Presbyterian-St. Lukes Medical Center, Chicago, IL.

To examine the role of the cholinergic system in Tourette syndrome, we administered intramuscular physostigmine and scopolamine hydrobromide to 10 patients, evaluating both motor tics and involuntary vocalizations. Patients showed a consistent abatement of motor tics and exacerbation of vocal tics after scopolamine injection. The scopolamine effect was reversed by physostigmine. These data suggest that the cholinergic system plays a role in the pharmacologic patho-physiology of Tourette syndrome. The pharmacology of vocal and motor tics may differ, and cholinergic manipulation may benefit some patients.

Address correspondence and reprint requests to Dr. Tanner, Department of Neurological Sciences, Rush-Presbyterian-St. Lukes Medical Center, 1725 West Harrison, Chicago, IL 60612.

This work was supported in part by the United Parkinson Foundation and the Boothroyd Foundation. Dr. Goetz is the recipient of a NINCDS Teacher Investigator Award.

These data were presented in part at the thirty-second annual meeting of the American Academy of Neurology, April 1980.

Accepted for publication March 8, 1982.




This article has been cited by other articles:


Home page
J PsychopharmacolHome page
J.V. Lucey
BAP/SKB Young Psychopharmacologist Award Towards a neuroendocrinology of obsessive-compulsive disorder
J Psychopharmacol, January 1, 1994; 8(4): 250 - 257.
[Abstract] [PDF]


Home page
Arch NeurolHome page
E. D. Caine
Gilles de la Tourette's Syndrome: A Review of Clinical and Research Studies and Consideration of Future Directions for Investigation
Arch Neurol, April 1, 1985; 42(4): 393 - 397.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by AAN Enterprises, Inc.